Sign in
CompletedNo phase

Bilateral Peribulbar Block for Cataract Surgery

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
50 people enrolled
Started
3 Jun 2025
Ended
30 Aug 2025
Type of study
Observational
Treatments tested
  • Bilateral peribulbar block
Record updated
24 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Both sexes
  • American Society of Anesthesiology (ASA) physical status I-III
  • Patients undergoing cataract surgery

Who cannot take part

  • Previously operated eyes
  • Infection at the site of the surgery
  • Allergy to any of the used drugs
  • Co-existing inflammatory conditions of eye
  • Coagulopathy
  • Posterior staphyloma
  • Bronchial asthma
  • Bradyarrhythmia
  • Pre-existing ocular muscle paresis
  • Neurological deficit
  • Complicated cataracts

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the safety and efficacy of bilateral peribulbar block for cataract surgery.

The group in the trial

  • Peribulbar anesthesia group

    Patients undergoing bilateral peribulbar anesthesia for cataract surgery

    Treatment: Bilateral peribulbar block

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety and Efficacy of Bilateral Peribulbar Block for Cataract Surgery
Record updated
24 April 2026